Carreon, Cristel D.
HRN: 24-30-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/03/2024
01/10/2024
IV
120mg
Q8hours
Acute Gastroenteritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes